A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

NCT01004016 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Spinocerebellar Degeneration

Interventions

DRUG: KPS-0373
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.